Search

Search Constraints

You searched for: Author/Creator Cavalli, Franco

Search Results

2. A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Issue 1 (2nd January 2022)

3. A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas. Issue 1 (6th November 2020)

4. Asociación de Hemato‐Oncología Pediátrica de Centro América (AHOPCA): A model for sustainable development in pediatric oncology. Issue 2 (18th October 2013)

5. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*. Issue 1 (2nd January 2019)

6. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study. Issue 1 (2nd January 2019)

7. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Issue 11 (November 2018)

9. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Issue 5 (May 2016)

10. Childhood acute lymphoblastic leukemia in Nicaragua: Long‐term results in the context of an international cooperative program. Issue 5 (27th December 2013)